Sign in to continue:

Wednesday, February 18th, 2026

Day: February 12, 2026

USP Group Limited Scheme of Arrangement: Creditors Meeting Notice and Key Dates (April 2026)

html USP Group Limited: Notice of Creditors’ Meeting for Proposed Scheme of Arrangement USP Group Limited Issues Notice of Creditors’ Meeting for Proposed Scheme of Arrangement Key Highlights for Investors USP Group Limited (Under...

Coliwoo Holdings Included in MSCI Global Micro Cap Indexes Singapore, Boosts Investor Visibility and Growth Potential 1

Coliwoo Holdings Included in MSCI Global Micro Cap Indexes – Singapore Coliwoo Holdings Limited to Join MSCI Global Micro Cap Indexes – Singapore: A Significant Milestone for Investors Key Highlights Coliwoo Holdings Limited (SGX:...

BRC Asia Limited Q1 2026 Business Update: Strong Financials Amid Robust Singapore Construction Sector Growth 123

BRC Asia Limited 1Q2026 Business Update: Key Insights for Investors BRC Asia Limited 1Q2026 Business Update: Key Insights for Investors Financial Highlights Revenue: S\$444.3 million for 1Q2026, reflecting robust demand and sustained sales momentum....

U.S. Government Awards iX Biopharma $41M Contract to Develop Wafermine® Ketamine Wafer for Military Pain Relief

iX Biopharma Secures US\$41 Million U.S. Government Contract for Wafermine® Development iX Biopharma Awarded US\$41 Million U.S. Defense Contract to Advance Wafermine® for Acute Pain Treatment Key Highlights iX Biopharma Ltd has secured a...

iX Biopharma Awarded US$41 Million U.S. Defense Contract for Development of Non-Opioid Sublingual Ketamine Pain Treatment Wafermine® 1

iX Biopharma Awarded US\$41 Million U.S. Government Contract iX Biopharma Secures US\$41 Million U.S. Department of Defense Contract for Non-Opioid Pain Treatment: A Potential Game-Changer for Shareholders Key Highlights iX Biopharma Ltd (SGX: 42C),...

iX Biopharma Announces S$6 Million Share Placement to Fund U.S. Government Contract Execution

html iX Biopharma Announces S\$6 Million Placement to Fund U.S. Government Contract iX Biopharma Announces S\$6 Million Placement to Fund U.S. Government Contract Key Points and Investor Highlights Proposed Placement: iX Biopharma Ltd. has...

Toku Secures Major European Enterprise Agreement, Expands AI-Powered Customer Experience Platform Across Europe

Toku Secures Multi-Market European Enterprise Agreement with Leading On-Demand Delivery Platform Toku Secures Multi-Market European Enterprise Agreement with Leading On-Demand Delivery Platform Key Highlights and Investment-Relevant Analysis Toku (SGX Catalist: TKU) enters the European...

Beng Kuang Marine FY2025 Corporate Highlights: Asset-Light Turnaround, Financial Resilience, and Offshore Marine Growth

Beng Kuang Marine FY2025 Financial Report: Investor Analysis Beng Kuang Marine Limited FY2025 Corporate Highlights: Investor Analysis Key Points and Highlights Resilient Profitability and Financial Performance: FY2025 revenue reached S\$98.16 million, with gross profit...

Beng Kuang Marine Maintains Profitability in FY2025 Despite Revenue Decline; Proposes Dividend and Strengthens Balance Sheet 14

Beng Kuang Marine FY2025 Results: Key Highlights for Investors Beng Kuang Marine Maintains Profitability and Strengthens Balance Sheet in FY2025 Amid Challenging Market Conditions Introduction Beng Kuang Marine Limited (“Beng Kuang Group”) has released...

TEHO International Announces Deregistration and Striking-Off of Dormant Subsidiaries in 2025

TEHO International Inc Ltd. – Corporate Update: Deregistration and Striking-Off of Dormant Subsidiaries TEHO International Inc Ltd. – Corporate Update: Deregistration and Striking-Off of Dormant Subsidiaries Key Highlights The Company has completed the deregistration...